Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1988 Mar 19;296(6625):814–816. doi: 10.1136/bmj.296.6625.814

Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure

D E Grobbee, W H L Hackeng, J C Birkenhäger, A Hofman
PMCID: PMC2545104  PMID: 3130926

Abstract

To study the role of parathyroid gland activity in early primary hypertension plasma concentrations of intact parathyroid hormone were measured in 90 untreated young subjects, aged 16-29, with stable mildly raised blood pressure and in 40 normotensive control subjects selected from the same population in Zoetermeer, The Netherlands. Intact parathyroid hormone concentration was significantly higher in the hypertensive than the normotensive group (2.34 (SE 0.11) pmol/l v 1·47 (0·13)pmol/l, respectively; difference 0·87 pmol/l; 95% confidence interval 0·55 to 1·21; p<0·0001). Serum total calcium concentration was 2·36 (0·01) mmol/l in the hypertensive group and 2·42 (0·01) mmol/l in the normotensive group (difference 0·06 mmol/l; 95% confidence interval 0·02 to 0·09; p=0·02). Urinary calcium excretion over 24 hours did not differ significantly between the two groups (4·17 (0·28) mmol/24 h in the hypertensive group and 3·89 (0·39) mmol/24 h in the normotensive group; difference 0·28 mmol/24 h; 95% confidence interval -0·66 to 1·22). In the hypertensive group both systolic and diastolic blood pressures increased slightly though significantly with intact parathyroid hormone concentrations. No obvious associations between serum calcium concentration and blood pressure were observed.

These findings support the view that enhanced activity of the parathyroid gland may play a part in the early stage of primary hypertension.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berthelot A., Gairard A. Parathyroid hormone- and deoxycorticosterone acetate-induced hypertension in the rat. Clin Sci (Lond) 1980 May;58(5):365–371. doi: 10.1042/cs0580365. [DOI] [PubMed] [Google Scholar]
  2. Bogin E., Massry S. G., Levi J., Djaldeti M., Bristol G., Smith J. Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Invest. 1982 Apr;69(4):1017–1025. doi: 10.1172/JCI110505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Daniels J., Goodman A. D. Hypertension and hyperparathyroidism. Inverse relation of serum phosphate level and blood pressure. Am J Med. 1983 Jul;75(1):17–23. doi: 10.1016/0002-9343(83)91162-2. [DOI] [PubMed] [Google Scholar]
  4. Erne P., Bolli P., Bürgisser E., Bühler F. R. Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med. 1984 Apr 26;310(17):1084–1088. doi: 10.1056/NEJM198404263101705. [DOI] [PubMed] [Google Scholar]
  5. Folsom A. R., Smith C. L., Prineas R. J., Grimm R. H., Jr Serum calcium fractions in essential hypertensive and matched normotensive subjects. Hypertension. 1986 Jan;8(1):11–15. doi: 10.1161/01.hyp.8.1.11. [DOI] [PubMed] [Google Scholar]
  6. Grobbee D. E., Hackeng W. H., Birkenhager J. C., Hofman A. Intact parathyroid hormone (1-84) in primary hypertension. Clin Exp Hypertens A. 1986;8(3):299–308. doi: 10.3109/10641968609039606. [DOI] [PubMed] [Google Scholar]
  7. Grobbee D. E., Hofman A. Effect of calcium supplementation on diastolic blood pressure in young people with mild hypertension. Lancet. 1986 Sep 27;2(8509):703–707. doi: 10.1016/s0140-6736(86)90228-x. [DOI] [PubMed] [Google Scholar]
  8. Grobbee D. E. Parathyroid hormone, electrolytes, and blood pressure. Lancet. 1987 Feb 14;1(8529):389–389. doi: 10.1016/s0140-6736(87)91766-1. [DOI] [PubMed] [Google Scholar]
  9. HELLSTROM J., BIRKE G., EDVALL C. A. Hypertension in hyperparathyroidism. Br J Urol. 1958 Mar;30(1):13–24. doi: 10.1111/j.1464-410x.1958.tb03498.x. [DOI] [PubMed] [Google Scholar]
  10. Habener J. F., Rosenblatt M., Potts J. T., Jr Parathyroid hormone: biochemical aspects of biosynthesis, secretion, action, and metabolism. Physiol Rev. 1984 Jul;64(3):985–1053. doi: 10.1152/physrev.1984.64.3.985. [DOI] [PubMed] [Google Scholar]
  11. Hackeng W. H., Lips P., Netelenbos J. C., Lips C. J. Clinical implications of estimation of intact parathyroid hormone (PTH) versus total immunoreactive PTH in normal subjects and hyperparathyroid patients. J Clin Endocrinol Metab. 1986 Aug;63(2):447–453. doi: 10.1210/jcem-63-2-447. [DOI] [PubMed] [Google Scholar]
  12. Henningsen N. C., Jaedig S., Reuterssvaed A. Calcium and blood pressure. Lancet. 1986 Nov 15;2(8516):1154–1155. doi: 10.1016/s0140-6736(86)90554-4. [DOI] [PubMed] [Google Scholar]
  13. Hofman A., Valkenburg H. A. Determinants of change in blood pressure during childhood. Am J Epidemiol. 1983 Jun;117(6):735–743. doi: 10.1093/oxfordjournals.aje.a113607. [DOI] [PubMed] [Google Scholar]
  14. Jones D. B., Jones J. H., Lloyd H. J., Lucas P. A., Wilkins W. E., Walker D. A. Changes in blood pressure and renal function after parathyroidectomy in primary hyperparathyroidism. Postgrad Med J. 1983 Jun;59(692):350–353. doi: 10.1136/pgmj.59.692.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kaplan N. M., Meese R. B. The calcium deficiency hypothesis of hypertension: a critique. Ann Intern Med. 1986 Dec;105(6):947–955. doi: 10.7326/0003-4819-105-6-947. [DOI] [PubMed] [Google Scholar]
  16. Lafferty F. W. Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests. Arch Intern Med. 1981 Dec;141(13):1761–1766. doi: 10.1001/archinte.141.13.1761. [DOI] [PubMed] [Google Scholar]
  17. Lindall A. W., Elting J., Ells J., Roos B. A. Estimation of biologically active intact parathyroid hormone in normal and hyperparathyroid sera by sequential N-terminal immunoextraction and midregion radioimmunoassay. J Clin Endocrinol Metab. 1983 Nov;57(5):1007–1014. doi: 10.1210/jcem-57-5-1007. [DOI] [PubMed] [Google Scholar]
  18. McCarron D. A., Morris C. D., Henry H. J., Stanton J. L. Blood pressure and nutrient intake in the United States. Science. 1984 Jun 29;224(4656):1392–1398. doi: 10.1126/science.6729459. [DOI] [PubMed] [Google Scholar]
  19. McCarron D. A., Pingree P. A., Rubin R. J., Gaucher S. M., Molitch M., Krutzik S. Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension. 1980 Mar-Apr;2(2):162–168. doi: 10.1161/01.hyp.2.2.162. [DOI] [PubMed] [Google Scholar]
  20. Palmieri G. M., Bertorini T. E., Nutting D. F. Calcium and blood pressure. Lancet. 1986 Nov 8;2(8515):1106–1106. doi: 10.1016/s0140-6736(86)90514-3. [DOI] [PubMed] [Google Scholar]
  21. Resnick L. M. Alterations of dietary calcium intake as a therapeutic modality in essential hypertension. Can J Physiol Pharmacol. 1986 Jun;64(6):803–807. doi: 10.1139/y86-137. [DOI] [PubMed] [Google Scholar]
  22. Robinson B. F. Altered calcium handling as a cause of primary hypertension. J Hypertens. 1984 Oct;2(5):453–460. doi: 10.1097/00004872-198410000-00002. [DOI] [PubMed] [Google Scholar]
  23. Schleiffer R., Berthelot A., Pernot F., Gairard A. Parathyroids, thyroid and development of hypertension in SHR. Jpn Circ J. 1981 Nov;45(11):1272–1279. doi: 10.1253/jcj.45.1272. [DOI] [PubMed] [Google Scholar]
  24. Sherwood L. M. Relative importance of parathyroid hormone and thyrocalcitonin in calcium homeostasis. N Engl J Med. 1968 Mar 21;278(12):663–670. doi: 10.1056/NEJM196803212781206. [DOI] [PubMed] [Google Scholar]
  25. Strazzullo P., Nunziata V., Cirillo M., Giannattasio R., Ferrara L. A., Mattioli P. L., Mancini M. Abnormalities of calcium metabolism in essential hypertension. Clin Sci (Lond) 1983 Aug;65(2):137–141. doi: 10.1042/cs0650137. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES